We are live on ! Find out more
BC

Broadfin Capital Portfolio holdings

AUM $747M
1-Year Est. Return 100.56%
This Fund
S&P 500
This Quarter Est. Return
-1.67%
1 Year Est. Return
+100.56%
3 Year Est. Return
+297.65%
5 Year Est. Return
+365.91%
10 Year Est. Return
–
AUM
$954M
AUM Growth
-$71.4M
Cap. Flow
-$2.48M
Cap. Flow %
-0.26%
Top 10 Hldgs %
46.58%
Holding
81
New
11
Increased
16
Reduced
19
Closed
9

Top Buys

Rank Stock Value
1
AMPH icon
Amphastar Pharmaceuticals
AMPH
+$20.6M
2
THOR
THORATEC CORPORATION
THOR
+$14.2M
3
VOLC
VOLCANO CORPORATION COM STK
VOLC
+$13.8M
4
PGNX
Progenics Pharmaceuticals Inc
PGNX
+$11.5M
5
KND
Kindred Healthcare
KND
+$10.8M

Top Sells

Rank Stock Value
1
BDSI
BioDelivery Sciences International, Inc.
BDSI
+$19.4M
2
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$15.5M
3
NVDQ
Novadaq Technologies Inc.
NVDQ
+$14.7M
4
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$13.5M
5
AMAG
AMAG Pharmaceuticals
AMAG
+$9.6M

Sector Composition

Rank Sector Weight
1 Healthcare 78.52%
2 Consumer Discretionary 0.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVAX
26
DELISTED
Dynavax Technologies
DVAX
$11M 1.15%
766,010
– –
LJPC
27
DELISTED
La Jolla Pharmaceutical Company
LJPC
$10.6M 1.12%
1,107,046
+719,325
+186% +$7.16M
VOLC
28
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$10.6M 1.11%
+994,854
New +$13.8M
TLGT
29
DELISTED
Teligent, Inc
TLGT
$10.6M 1.11%
113,481
-96,519
-46% -$6.18M
CEMP
30
DELISTED
Cempra, Inc.
CEMP
$10.5M 1.1%
955,147
– –
ELOS
31
DELISTED
Syneron Medical Ltd
ELOS
$10.1M 1.06%
1,005,221
– –
BKD icon
32
Brookdale Senior Living
BKD
$3.58B
$9.76M 1.02%
303,000
– –
KND
33
DELISTED
Kindred Healthcare
KND
$9.61M 1.01%
+495,300
New +$10.8M
CARM
34
DELISTED
Carisma Therapeutics
CARM
$9.55M 1%
42,886
– –
CRDC
35
DELISTED
CARDICA INC COM NEW (DE)
CRDC
$9.5M 1%
887,399
-100
-0% -$1.13K
CORI
36
DELISTED
Corium International, Inc.
CORI
$8.6M 0.9%
1,400,000
– –
RAD
37
DELISTED
Rite Aid Corporation
RAD
$8.11M 0.85%
83,750
+3,750
+5% +$484K
ACGN
38
DELISTED
Aceragen Inc
ACGN
$8.07M 0.85%
25,950
– –
TENX icon
39
Tenax Therapeutics
TENX
$420M
$7.74M 0.81%
62
– –
XNCR icon
40
Xencor
XNCR
$1.3B
$7.02M 0.74%
753,683
-21,198
-3% -$214K
ATRS
41
DELISTED
Antares Pharma, Inc.
ATRS
$6.77M 0.71%
3,700,000
+650,000
+21% +$1.42M
ZGNX
42
DELISTED
Zogenix, Inc.
ZGNX
$6.48M 0.68%
704,706
+62,500
+10% +$711K
DRRX
43
DELISTED
DURECT Corp
DRRX
$6.47M 0.68%
440,450
– –
VXRT
44
DELISTED
Vaxart
VXRT
$6.45M 0.68%
237,428
+135,416
+133% +$3.88M
AFAM
45
DELISTED
Almost Family Inc
AFAM
$6.09M 0.64%
+224,230
New +$5.81M
ADYX
46
DELISTED
Adynxx Inc
ADYX
$6M 0.63%
+25,755
New +$8.24M
CNMD icon
47
CONMED
CNMD
$1.3B
$5.53M 0.58%
+150,000
New +$5.95M
QLTI
48
DELISTED
QLT Inc
QLTI
$5.18M 0.54%
1,145,527
-182,865
-14% -$1.03M
RXDX
49
DELISTED
Ignyta, Inc.
RXDX
$5.17M 0.54%
225,000
– –
PLXP
50
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$4.73M 0.5%
59,375
– –
1
2
3 4

Similar funds

CBU
CIBC Bank USA Chicago, Illinois $756M AUM 24.68% 1-Year Est. Return
CONA
Capital One National Association New York $756M AUM
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
SC
Selz Capital New York $570M AUM 35.56% 1-Year Est. Return
KGACF
Kopernik Global All-Cap Fund Tampa, Florida $558M AUM
BPWA
Beacon Pointe Wealth Advisors Newport Beach, California $543M AUM 23.61% 1-Year Est. Return
TRAM
Tuscan Ridge Asset Management Chicago, Illinois $984M AUM 25.8% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return

Broadfin Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Broadfin Capital held 81 positions worth $954M, down 7% from $1.03B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Broadfin Capital's Q3 2014 filing shows 11 new, 16 increased, 19 reduced and 9 closed positions. Its largest new stake was Amphastar Pharmaceuticals: 1,977,854 shares worth $23M. The largest sale was BioDelivery Sciences International, Inc., an estimated $19.4M.

By sector, the portfolio is most concentrated in Healthcare at 79% of assets, down from 80% a quarter earlier, followed by Consumer Discretionary.

  • Broadfin Capital's largest Q3 2014 buy was Amphastar Pharmaceuticals: 1,977,854 shares worth $23M.
  • Broadfin Capital added most to Progenics Pharmaceuticals Inc in Q3 2014, an estimated $11.5M increase.
  • Broadfin Capital's biggest Q3 2014 reduction was BioDelivery Sciences International, Inc., cutting an estimated $19.4M.
  • Broadfin Capital fully exited Option Care Health in Q3 2014, selling an estimated $9.58M.
  • Broadfin Capital's ten largest holdings make up 47% of its $954M portfolio in Q3 2014.
  • Broadfin Capital opened 11 new positions and closed 9 in Q3 2014.
  • Broadfin Capital's portfolio value fell 7% quarter-over-quarter to $954M.

Based on Broadfin Capital's 13F filing for Q3 2014, filed 14 Nov 2014.